|
Monday 14th February 2011 |
Text too small? |
Pharmacybrands Group is to buy the shares in Radius Pharmacy for $17.1 million, with an assumption of debt of $18 million, subject to net asset and other adjustments.
Pharmacybrands today said the agreement was conditional on the approval of its shareholders, who were expected to meet in late March, and completion of finance arrangements.
Radius Pharmacy holds interests in 34 pharmacies and has annual revenue around $86 million.
Pharmacybrands said Radius Pharmacy would be a strong fit with its existing business, strengthening its ability to invest in systems and other resources to enhance the services to pharmacies operating under its brands.
Retail competition was primarily from other channels and the company must invest in the tools and developing the skills to compete effectively, at the same time as investing in new service opportunities in primary care, Pharmacybrands chief executive Alan Wham said.
NZPA
No comments yet
February 20th Morning Report
SCL - Chief Financial Officer Transition
BLS - Strong YTD performance
CEN announces opening of NZ$75 million Retail Offer
AIA - 1H26 Interim Results
February 19th Morning Report
TWL - Share Purchase Plan Results
GMT revaluation, unit buyback and proposed structure update
Devon Funds Morning Note - 17 February 2026
CEN - Contact successfully completes NZ$450m Placement